185 related articles for article (PubMed ID: 15184704)
1. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.
Girdler SS; Thompson KS; Light KC; Leserman J; Pedersen CA; Prange AJ
Psychosom Med; 2004; 66(3):403-10. PubMed ID: 15184704
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: association with histories of sexual abuse.
Bunevicius A; Leserman J; Girdler SS
Psychosom Med; 2012 Oct; 74(8):810-6. PubMed ID: 23001392
[TBL] [Abstract][Full Text] [Related]
3. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls.
Girdler SS; Sherwood A; Hinderliter AL; Leserman J; Costello NL; Straneva PA; Pedersen CA; Light KC
Psychosom Med; 2003; 65(5):849-56. PubMed ID: 14508031
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
[TBL] [Abstract][Full Text] [Related]
5. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
Beddig T; Reinhard I; Kuehner C
Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
[TBL] [Abstract][Full Text] [Related]
6. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
Reed SC; Levin FR; Evans SM
Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
[TBL] [Abstract][Full Text] [Related]
7. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
[TBL] [Abstract][Full Text] [Related]
8. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.
Bunevicius R; Hinderliter AL; Light KC; Leserman J; Pedersen CA; Girdler SS
Biol Psychol; 2005 Jul; 69(3):281-96. PubMed ID: 15925031
[TBL] [Abstract][Full Text] [Related]
9. Altered binding of serum thyroid hormone to thyroxine-binding globulin in women with functional hypothalamic amenorrhea.
Dominguez CE; Laughlin GA; Nelson JC; Yen SS
Fertil Steril; 1997 Dec; 68(6):992-6. PubMed ID: 9418685
[TBL] [Abstract][Full Text] [Related]
10. Thyroid axis function during the menstrual cycle in women with premenstrual syndrome.
Girdler SS; Pedersen CA; Light KC
Psychoneuroendocrinology; 1995; 20(4):395-403. PubMed ID: 8532823
[TBL] [Abstract][Full Text] [Related]
11. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
[TBL] [Abstract][Full Text] [Related]
12. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
[TBL] [Abstract][Full Text] [Related]
13. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
[TBL] [Abstract][Full Text] [Related]
14. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
Yen JY; Lin PC; Huang MF; Chou WP; Long CY; Ko CH
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033286
[TBL] [Abstract][Full Text] [Related]
15. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder.
Straneva PA; Maixner W; Light KC; Pedersen CA; Costello NL; Girdler SS
Health Psychol; 2002 Jul; 21(4):358-67. PubMed ID: 12090678
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases.
Le Mellédo JM; Merani S; Koszycki D; Bellavance F; Palmour R; Gutkowska J; Steinberg S; Bichet DG; Bradwejn J
Neuropsychopharmacology; 1999 Jan; 20(1):81-91. PubMed ID: 9885787
[TBL] [Abstract][Full Text] [Related]
17. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
Thys-Jacobs S; McMahon D; Bilezikian JP
J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder.
Girdler SS; Pedersen CA; Straneva PA; Leserman J; Stanwyck CL; Benjamin S; Light KC
Psychiatry Res; 1998 Nov; 81(2):163-78. PubMed ID: 9858034
[TBL] [Abstract][Full Text] [Related]
19. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy.
Baumgartner A; von Stuckrad M; Müller-Oerlinghausen B; Gräf KJ; Kürten I
J Affect Disord; 1995 Jun; 34(3):211-8. PubMed ID: 7560549
[TBL] [Abstract][Full Text] [Related]
20. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
Nyberg S; Wahlström G; Bäckström T; Sundström Poromaa I
Psychoneuroendocrinology; 2004 Jul; 29(6):767-77. PubMed ID: 15110926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
